维普期刊资源整合服务平台（V6.5）

99篇 您的检索式：作者名="SCHUTT P"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia显示文摘	FLASSHOVE M MEUSERS P SCHUTTE J	2000	Ann Hematol2000，79，：	1
2	Molecular analysis of C1 alleles in Zea mays defines regions involved in the expression of this regulatory gene显示文摘	Scheffler B Franken P Schutt E	1994	Mol Gen Genet1994，242，1：	1
3	Soluble MICA as an independent prognostic factor for the overall survival and progression- free survival of muhiple myeloma patients显示文摘	Rebmann V Schutt P Brandhorst D	2007	Clin Immunol2007，123，1：	1
4	Redistribution of glutathione in the ischemic rat retina显示文摘	Schutte M Werner P	1998	Neurosci Lett1998，246，1：	1
5	Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study显示文摘	Mayer T Schutte W Wolf P	1999	Acta Neurol Scand1999，99，1：	1
6	Barometric hazards within the context of deep-level mining 显示文摘	Franz R M Schutte P C	2005	The Journal of the South African Institute of Mining and Metallurgy2005，105，7：	1
7	Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma:serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival显示文摘	Schutt P Ebeling P Buttkereit U		0，，：	1
8	Redistribution of glutathione in the ischemic retina显示文摘	Schutte M Werner P	1998	Neurosci Lett1998，，：	1
9	Design of HVDC converter stations with respect to audible noise requirements 显示文摘	SMEDE J JOHANSSON C G WINROTH O SCHUTT H P	1995	IEEE Transactions on Power Delivery1995，10，2：	1
10	Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma显示文摘	Schutt P Ebeling P Buttkereit U	2005	Eur J Haematol2005，74，1：	1
11	Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia显示文摘	FLASSHOVE M MEUSERS P SCHUTTE J	2000	Ann Hematol2000，79，：	1
12	Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients 显示文摘	REBMANN V SCHUTT P BRANDHORST D	2007	Clin Immunol2007，123，1：	1
13	Soulble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients显示文摘	Rebmann V Schutt P Brandhorst D	2007	Clin Immonol2007，123，1：	1
14	Discovery of five conserved β-defensin gene clusters using a computational search strategy显示文摘	Schutte B C Mitros J P Bartlett J A	2002	Proc Natl Acad Sci USA2002，99，4：	1
15	Markers for predicting severity andprogression of acute pancreatitis显示文摘	Schutte K Malfertheiner P	2008	Best Pract Res Clin Gastroen-terol2008，22，1：	1
16	Ifosfamide, etoposide, cytarabine,and dexamethasone as salvage treatment followed by high - dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas显示文摘	Schutt P Passon J Ebeling P	2007	Eur J Haematol2007，78，2：	1
17	Hepatocellular carci- noma epidemiologieal trends and risk factors显示文摘	Schutte K Bornschein J Malfertheiner P	2009	Dig Dis2009，27，2：	1
18	FDG-PET/CT in re-staging of patients with lymphoma显示文摘	Freudenberg LS Antoch G Schutt P	2004	Eur J Nucl Med Mol Imaging2004，31，3：	1
19	The endogenous survival promotion of axotomized rat corticospinal neurons by brain-derived neurotrophic factor is mediated via paracrine,rather than autocrine mechanism显示文摘	Yan Q Mestres P	2000	Neurosci Lett2000，290，3：	1
20	Discovery of new human β- defensins using a genomics-based approach 显示文摘	Jia H P Schutte B C Schudy A	2001	Gene2001，263，12：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示